This content is restricted to members.
To view our premium content, sign up for a membership:
This content is restricted to members.
To view our premium content, sign up for a membership:
References
1.Li J, Guasch-Ferré M, Li Y, Hu FB. Dietary intake and biomarkers of linoleic acid and mortality: systematic review and meta-analysis of prospective cohort studies. Am J Clin Nutr. 2020 Jul 1;112(1):150–67.
2.Farvid MS. Dietary Linoleic Acid and Risk of Coronary Heart Disease: A Systematic Review and Meta-Analysis of Prospective Cohort Studies. Circulation. 2015;130(18):1568–78.
3.Marklund M, Wu JHY, Imamura F, del Gobbo LC, Fretts A, de Goede J, et al. Biomarkers of Dietary Omega-6 Fatty Acids and Incident Cardiovascular Disease and Mortality. Circulation. 2019 May 21;139(21):2422–36.
4.Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: A systematic review and meta-analysis of randomized controlled trials. PLoS Med. 2010;7(3).
5.Hooper L, Martin N, Jimoh OF, Kirk C, Foster E, Abdelhamid AS. Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews. 2020 May 19;5(5):CD011737.
6.Keys A, Anderson JT, Grande F. Prediction of Serum-Cholesterol Responses of Man to Changes in Fat in the Diet. The Lancet. 1957;Nov 16(73(7003)):959-966.
7.Hegsted MD, Ausman LM, Johnson JA, Dallal GE. Fat and Serum Lipids: Am J Clin Nutr. 1993;57(6):875–83.
8.Clarke R, Frost C, Collins R, Appleby PN, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ. 1997;314:112–7.
9.Ruscica M, Sirtori CR, Carugo S, Calder PC, Corsini A. Omega-3 and cardiovascular prevention – Is this still a choice? Pharmacol Res. 2022 Aug;182:106342.
10.Farukhi ZM, Mora S, Manson JE. Marine Omega-3 Fatty Acids and Cardiovascular Disease Prevention: Seeking Clearer Water. Mayo Clin Proc. 2021 Feb;96(2):277–9.
11.Toth PP, Chapman MJ, Parhofer KG, Nelson JR. Differentiating EPA from EPA/DHA in cardiovascular risk reduction. American Heart Journal Plus: Cardiology Research and Practice. 2022 May;17:100148.
12.Sheppard JP, Lakshmanan S, Dahal S, Roy SK, Bhatt DL, Budoff MJ, et al. EPA Versus Mixed EPA/DHA Plus Statin for Coronary Atherosclerosis. JACC Cardiovasc Imaging. 2022 Oct;15(10):1825–8.
13.Arab L, Akbar J. Biomarkers and the measurement of fatty acids. Public Health Nutr. 2002 Dec 22;5(6a):865–71.
14.Harris WS, Thomas RM. Biological variability of blood omega-3 biomarkers. Clin Biochem. 2010 Feb;43(3):338–40.
15.Ramsden CE, Zamora D, Leelarthaepin B, Majchrzak-Hong SF, Faurot KR, Suchindran CM, et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ. 2013 Feb 4;346(feb04 3):e8707–e8707.
16.Calder PC, Ahluwalia N, Albers R, Bosco N, Bourdet-Sicard R, Haller D, et al. A Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies. British Journal of Nutrition. 2013 Jan 23;109(S1):S1–34.
17.Rett BS, Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: A systematic review. Nutr Metab (Lond). 2011;8:1–15.
18.Johnson GH, Fritsche K. Effect of Dietary Linoleic Acid on Markers of Inflammation in Healthy Persons: A Systematic Review of Randomized Controlled Trials. J Acad Nutr Diet. 2012;112(7):1029-1041.e15
19.Bradbury J. Docosahexaenoic acid (DHA): An ancient nutrient for the modern human brain. Nutrients. 2011;3(5):529–54.
20.Cunnane SC, Chouinard-Watkins R, Castellano CA, Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer’s disease: Can we reconcile the evidence? Prostaglandins Leukot Essent Fatty Acids. 2013;88(1):61–70.
21.Hu Y, Hu FB, Manson JAE. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants. J Am Heart Assoc. 2019;8(19):e013543.
22.Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, Shearman CP, et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. The Lancet. 2003 Feb;361(9356):477–85.
23.Cawood AL, Ding R, Napper FL, Young RH, Williams JA, Ward MJA, et al. Eicosapentaenoic acid (EPA) from highly concentrated n−3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis. 2010 Sep;212(1):252–9.
24.Yuhas R, Pramuk K, Lien EL. Human milk fatty acid composition from nine countries varies most in DHA. Lipids. 2006 Sep;41(9):851–8.